Short-term natural history of non-perfusion areas in treatment-naive diabetic retinopathy patients using swept-source OCT angiography.
| Title: | Short-term natural history of non-perfusion areas in treatment-naive diabetic retinopathy patients using swept-source OCT angiography. |
|---|---|
| Authors: | Ding X; Harvard Retinal Imaging Lab, Department of Ophthalmology, Massachusetts Eye and Ear, Harvard Medical School, Boston, MA, USA.; Retina Service, Department of Ophthalmology, Massachusetts Eye and Ear, Harvard Medical School, 243 Charles Street , Boston, MA, 02114, USA.; Romano F; Harvard Retinal Imaging Lab, Department of Ophthalmology, Massachusetts Eye and Ear, Harvard Medical School, Boston, MA, USA.; Retina Service, Department of Ophthalmology, Massachusetts Eye and Ear, Harvard Medical School, 243 Charles Street , Boston, MA, 02114, USA.; Garcia MD; Harvard Retinal Imaging Lab, Department of Ophthalmology, Massachusetts Eye and Ear, Harvard Medical School, Boston, MA, USA.; Garg I; Harvard Retinal Imaging Lab, Department of Ophthalmology, Massachusetts Eye and Ear, Harvard Medical School, Boston, MA, USA.; Gan J; Harvard Retinal Imaging Lab, Department of Ophthalmology, Massachusetts Eye and Ear, Harvard Medical School, Boston, MA, USA.; Overbey KM; Harvard Retinal Imaging Lab, Department of Ophthalmology, Massachusetts Eye and Ear, Harvard Medical School, Boston, MA, USA.; Vingopoulos F; Harvard Retinal Imaging Lab, Department of Ophthalmology, Massachusetts Eye and Ear, Harvard Medical School, Boston, MA, USA.; Bennett CF; Harvard Retinal Imaging Lab, Department of Ophthalmology, Massachusetts Eye and Ear, Harvard Medical School, Boston, MA, USA.; Shan M; Harvard Retinal Imaging Lab, Department of Ophthalmology, Massachusetts Eye and Ear, Harvard Medical School, Boston, MA, USA.; Stettler I; Harvard Retinal Imaging Lab, Department of Ophthalmology, Massachusetts Eye and Ear, Harvard Medical School, Boston, MA, USA.; Finn MJ; Harvard Retinal Imaging Lab, Department of Ophthalmology, Massachusetts Eye and Ear, Harvard Medical School, Boston, MA, USA.; Vavvas DG; Retina Service, Department of Ophthalmology, Massachusetts Eye and Ear, Harvard Medical School, 243 Charles Street , Boston, MA, 02114, USA.; Husain D; Retina Service, Department of Ophthalmology, Massachusetts Eye and Ear, Harvard Medical School, 243 Charles Street , Boston, MA, 02114, USA.; Wu DM; Retina Service, Department of Ophthalmology, Massachusetts Eye and Ear, Harvard Medical School, 243 Charles Street , Boston, MA, 02114, USA.; Patel NA; Retina Service, Department of Ophthalmology, Massachusetts Eye and Ear, Harvard Medical School, 243 Charles Street , Boston, MA, 02114, USA.; Kim LA; Retina Service, Department of Ophthalmology, Massachusetts Eye and Ear, Harvard Medical School, 243 Charles Street , Boston, MA, 02114, USA.; Miller JB; Harvard Retinal Imaging Lab, Department of Ophthalmology, Massachusetts Eye and Ear, Harvard Medical School, Boston, MA, USA. john_miller@meei.harvard.edu.; Retina Service, Department of Ophthalmology, Massachusetts Eye and Ear, Harvard Medical School, 243 Charles Street , Boston, MA, 02114, USA. john_miller@meei.harvard.edu. |
| Source: | Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie [Graefes Arch Clin Exp Ophthalmol] 2026 Mar 31. Date of Electronic Publication: 2026 Mar 31. |
| Publication Model: | Ahead of Print |
| Publication Type: | Journal Article |
| Language: | English |
| Journal Info: | Publisher: Springer-Verlag Country of Publication: Germany NLM ID: 8205248 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1435-702X (Electronic) Linking ISSN: 0721832X NLM ISO Abbreviation: Graefes Arch Clin Exp Ophthalmol Subsets: MEDLINE |
| Imprint Name(s): | Original Publication: Berlin ; New York : Springer-Verlag, c1982- |
| Competing Interests: | Declarations. Research Ethics Approval: This study involves human participants and was approved by the Institutional 29 Review Board of Massachusetts General Brigham (protocol: 2019P001863). Conflict of interest: no conflicting relationship relevant to this research. Financial Disclosures: JBM is a consultant for Alcon, Allergan, Carl Zeiss, Sunovion, Topcon, and Genentech. DGV has been an advisor to Drusolv; is an inventor on patents of Neuroprotection held by Mass Eye and Ear. DH is a consultant for Allergan, Genetech, Omeicos Therapeutics, and has received financial support from National Eye Institute, Lions VisionGift, Commonwealth Grant, Lions International and the Macula Society. LAK is a consultant for Ingenia Therapeutics, CureVac AG, Pykus Therapeutics, and has received grant support from the National Eye Institute and the Department of Defense. NAP is a consultant for Regeneron, Dutch Ophthalmic, Genentech, EyePoint Pharmaceuticals, Alcon Vision. DMW has a patent through Massachusetts Eye and Ear. XD, FR, IG, JG, KMO, MDG, FV, IS, MS, MJF, CFB have no relevant financial disclosures. |
| References: | Ting DS, Cheung GC, Wong TY (2016) Diabetic retinopathy: global prevalence, major risk factors, screening practices and public health challenges: a review. Clin Exp Ophthalmol 44(4):260–277 Epub 20160217. https://doi.org/10.1111/ceo.12696. (PMID: 10.1111/ceo.1269626716602); Teo ZL, Tham YC, Yu M, Chee ML, Rim TH, Cheung N, Bikbov MM, Wang YX, Tang Y, Lu Y, Wong IY, Ting DSW, Tan GSW, Jonas JB, Sabanayagam C, Wong TY, Cheng CY (2021) Global Prevalence of Diabetic Retinopathy and Projection of Burden through 2045: Systematic Review and Meta-analysis. Ophthalmology 128(11):1580–1591 Epub 20210501. https://doi.org/10.1016/j.ophtha.2021.04.027. (PMID: 10.1016/j.ophtha.2021.04.02733940045); Ferris FL (1993) 3rd. How effective are treatments for diabetic retinopathy? JAMA 269(10):1290–1291 PubMed PMID: 8437309. (PMID: 10.1001/jama.1993.035001000880348437309); Klonoff DC, Schwartz DM (2000) An economic analysis of interventions for diabetes. Diabetes Care 23(3):390–404. https://doi.org/10.2337/diacare.23.3.390 PubMed PMID: 10868871. (PMID: 10.2337/diacare.23.3.39010868871); Rein DB, Zhang P, Wirth KE, Lee PP, Hoerger TJ, McCall N, Klein R, Tielsch JM, Vijan S, Saaddine J (2006) The economic burden of major adult visual disorders in the United States. Arch Ophthalmol 124(12):1754–1760. https://doi.org/10.1001/archopht.124.12.1754 PubMed PMID: 17159036. (PMID: 10.1001/archopht.124.12.175417159036); Group UKPDS (1998) Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group. BMJ 317(7160):703–713 PubMed PMID: 9732337; PMCID: PMC28659. (PMID: 10.1136/bmj.317.7160.703); Nathan DM, Cleary PA, Backlund JY, Genuth SM, Lachin JM, Orchard TJ, Raskin P, Zinman B, Diabetes C (2005) Complications Trial/Epidemiology of Diabetes I, Complications Study Research G. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med 353(25):2643–2653. https://doi.org/10.1056/NEJMoa052187 PubMed PMID: 16371630; PMCID: PMC2637991. (PMID: 10.1056/NEJMoa052187163716302637991); Hirai FE, Moss SE, Klein BE, Klein R (2008) Relationship of glycemic control, exogenous insulin, and C-peptide levels to ischemic heart disease mortality over a 16-year period in people with older-onset diabetes: the Wisconsin Epidemiologic Study of Diabetic Retinopathy (WESDR). Diabetes Care 31(3):493–497 Epub 20071119. https://doi.org/10.2337/dc07-1161. (PMID: 10.2337/dc07-116118025409); Flaxel CJ, Adelman RA, Bailey ST, Fawzi A, Lim JI, Vemulakonda GA, Ying GS (2020) Diabetic Retinopathy Preferred Practice Pattern(R). Ophthalmology 127(1):P66–P145 Epub 20190925. https://doi.org/10.1016/j.ophtha.2019.09. (PMID: 10.1016/j.ophtha.2019.0931757498); Lin KY, Hsih WH, Lin YB, Wen CY, Chang TJ (2021) Update in the epidemiology, risk factors, screening, and treatment of diabetic retinopathy. J Diabetes Investig 12(8):1322–1325 Epub 20210114. https://doi.org/10.1111/jdi.13480. (PMID: 10.1111/jdi.13480333161448354492); Sun WJ, An XD, Zhang YH, Zhao XF, Sun YT, Yang CQ, Kang XM, Jiang LL, Ji HY, Lian FM (2023) The ideal treatment timing for diabetic retinopathy: the molecular pathological mechanisms underlying early-stage diabetic retinopathy are a matter of concern. Front Endocrinol (Lausanne) 14:1270145 Epub 20231109. https://doi.org/10.3389/fendo.2023.1270145. (PMID: 10.3389/fendo.2023.12701453802713110680169); Wykoff CC, Yu HJ, Avery RL, Ehlers JP, Tadayoni R, Sadda SR (2022) Retinal non-perfusion in diabetic retinopathy. Eye (Lond) 36(2):249–256 Epub 20220111. https://doi.org/10.1038/s41433-021-01649-0. (PMID: 10.1038/s41433-021-01649-0350177008807828); Ofuji Y, Katada Y, Tomita Y, Nagai N, Sonobe H, Watanabe K, Shinoda H, Ozawa Y, Negishi K, Tsubota K, Kurihara T (2022) Non-Perfusion Area Index for Prognostic Prediction in Diabetic Retinopathy. Life (Basel). ;12(4). Epub 20220406. https://doi.org/10.3390/life12040542 . PubMed PMID: 35455032; PMCID: PMC9031699.; Huang Z, Qiu K, Yi J, Lin H, Zheng D, Huang D, Zhang G, Chen H, Zheng J, Wang Y, Fang D, Chen W (2022) Diabetic retinopathy with extensively large area of capillary non-perfusion: characteristics and treatment outcomes. BMC Ophthalmol 22(1):293 Epub 20220704. https://doi.org/10.1186/s12886-022-02508-6. (PMID: 10.1186/s12886-022-02508-6357872719254521); Couturier A, Rey PA, Erginay A, Lavia C, Bonnin S, Dupas B, Gaudric A, Tadayoni R (2019) Widefield OCT-Angiography and Fluorescein Angiography Assessments of Nonperfusion in Diabetic Retinopathy and Edema Treated with Anti-Vascular Endothelial Growth Factor. Ophthalmology 126(12):1685–1694 Epub 20190626. https://doi.org/10.1016/j.ophtha.2019.06.022. (PMID: 10.1016/j.ophtha.2019.06.02231383483); Wang M, Garg I, Miller JB (2021) Wide Field Swept Source Optical Coherence Tomography Angiography for the Evaluation of Proliferative Diabetic Retinopathy and Associated Lesions: A Review. Semin Ophthalmol 36(4):162–167 PubMed PMID: 33734945. (PMID: 10.1080/08820538.2021.188790133734945); Horie S, Ohno-Matsui K (2022) Progress of Imaging in Diabetic Retinopathy-From the Past to the Present. Diagnostics (Basel). ;12(7). Epub 20220711. https://doi.org/10.3390/diagnostics12071684 . PubMed PMID: 35885588; PMCID: PMC9319818.; Cui Y, Zhu Y, Wang JC, Lu Y, Zeng R, Katz R, Vingopoulos F, Le R, Lains I, Wu DM, Eliott D, Vavvas DG, Husain D, Miller JW, Kim LA, Miller JB (2021) Comparison of widefield swept-source optical coherence tomography angiography with ultra-widefield colour fundus photography and fluorescein angiography for detection of lesions in diabetic retinopathy. Br J Ophthalmol 105(4):577–581 Epub 20200626. https://doi.org/10.1136/bjophthalmol-2020-316245. (PMID: 10.1136/bjophthalmol-2020-31624532591347); Garg I, Uwakwe C, Le R, Lu ES, Cui Y, Wai KM, Katz R, Zhu Y, Moon JY, Li CY, Lains I, Eliott D, Elze T, Kim LA, Wu DM, Miller JW, Husain D, Vavvas DG, Miller JB (2022) Nonperfusion Area and Other Vascular Metrics by Wider Field Swept-Source OCT Angiography as Biomarkers of Diabetic Retinopathy Severity. Ophthalmol Sci 2(2) Epub 20220318. https://doi.org/10.1016/j.xops.2022.100144.; Wilkinson CP, Ferris FL 3rd, Klein RE, Lee PP, Agardh CD, Davis M, Dills D, Kampik A, Pararajasegaram R, Verdaguer JT (2003) Global Diabetic Retinopathy Project G. Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology 110(9):1677–1682. https://doi.org/10.1016/S0161-6420(03)00475-5 PubMed PMID: 13129861. (PMID: 10.1016/S0161-6420(03)00475-513129861); Lu Y, Wang JC, Zeng R, Katz R, Vavvas DG, Miller JW, Miller JB (2019) Quantitative Comparison Of Microvascular Metrics On Three Optical Coherence Tomography Angiography Devices In Chorioretinal Disease. Clin Ophthalmol 13:2063–2069 Epub 20191022. https://doi.org/10.2147/OPTH.S215322. (PMID: 10.2147/OPTH.S215322317496036816077); Garg I, Miller JB (2023) Semi-automated algorithm using directional filter for the precise quantification of non-perfusion area on widefield swept-source optical coherence tomography angiograms. Quant Imaging Med Surg 0(0):0. https://doi.org/10.21037/qims-21-1175. (PMID: 10.21037/qims-21-1175); Wijesingha N, Tsai WS, Keskin AM, Holmes C, Kazantzis D, Chandak S, Kubravi H, Sivaprasad S (2024) Optical Coherence Tomography Angiography as a Diagnostic Tool for Diabetic Retinopathy. Diagnostics (Basel) 14(3) Epub 20240202. https://doi.org/10.3390/diagnostics14030326.; Schaal KB, Munk MR, Wyssmueller I, Berger LE, Zinkernagel MS, Wolf S (2019) Vascular Abnormalities in Diabetic Retinopathy Assessed with Swept-Source Optical Coherence Tomography Angiography Widefield Imaging. Retina 39(1):79–87 /IAE.0000000000001938. PubMed PMID: 29135803. (PMID: 10.1097/IAE.000000000000193829135803); Vujosevic S, Aldington SJ, Silva P, Hernandez C, Scanlon P, Peto T, Simo R (2020) Screening for diabetic retinopathy: new perspectives and challenges. Lancet Diabetes Endocrinol 8(4):337–347 Epub 20200227. https://doi.org/10.1016/S2213-8587(19)30411-5. (PMID: 10.1016/S2213-8587(19)30411-532113513); Antaki F, Coussa RG, Mikhail M, Archambault C, Lederer DE (2020) The prognostic value of peripheral retinal nonperfusion in diabetic retinopathy using ultra-widefield fluorescein angiography. Graefes Arch Clin Exp Ophthalmol. ;258(12):2681-90. Epub 20200716. https://doi.org/10.1007/s00417-020-04847-w . PubMed PMID: 32676792.; Niki T, Muraoka K, Shimizu K (1984) Distribution of capillary nonperfusion in early-stage diabetic retinopathy. Ophthalmology 91(12):1431–1439. https://doi.org/10.1016/s0161-6420(84)34126-4 PubMed PMID: 6084212. (PMID: 10.1016/s0161-6420(84)34126-46084212); Reddy RK, Pieramici DJ, Gune S, Ghanekar A, Lu N, Quezada-Ruiz C, Baumal CR (2018) Efficacy of Ranibizumab in Eyes with Diabetic Macular Edema and Macular Nonperfusion in RIDE and RISE. Ophthalmology 125(10):1568–1574 Epub 20180508. https://doi.org/10.1016/j.ophtha.2018.04.002. (PMID: 10.1016/j.ophtha.2018.04.00229752001); Kim YJ, Yeo JH, Son G, Kang H, Sung YS, Lee JY, Kim JG, Yoon YH (2020) Efficacy of intravitreal AFlibercept injection For Improvement of retinal Nonperfusion In diabeTic retinopathY (AFFINITY study). BMJ Open Diabetes Res Care 8(1). https://doi.org/10.1136/bmjdrc-2020-001616 PubMed PMID: 33077475; PMCID: PMC7574886.; Bahr TA, Bakri SJ (2023) Update on the Management of Diabetic Retinopathy: Anti-VEGF Agents for the Prevention of Complications and Progression of Nonproliferative and Proliferative Retinopathy. Life (Basel). ;13(5). Epub 20230427. https://doi.org/10.3390/life13051098 . PubMed PMID: 37240743; PMCID: PMC10222751.; Fan W, Wang K, Ghasemi Falavarjani K, Sagong M, Uji A, Ip M, Wykoff CC, Brown DM, van Hemert J, Sadda SR (2017) Distribution of Nonperfusion Area on Ultra-widefield Fluorescein Angiography in Eyes With Diabetic Macular Edema: DAVE Study. Am J Ophthalmol 180:110–116 Epub 20170601. https://doi.org/10.1016/j.ajo.2017.05.024. (PMID: 10.1016/j.ajo.2017.05.02428579062) |
| Contributed Indexing: | Keywords: diabetic retinopathy; non-perfusion areas; progression; swept-source OCTA |
| Entry Date(s): | Date Created: 20260331 Latest Revision: 20260331 |
| Update Code: | 20260331 |
| DOI: | 10.1007/s00417-026-07186-4 |
| PMID: | 41915053 |
| Database: | MEDLINE |
Journal Article